The Effect of Autologous Serum Eye Drops on the Conjunctivalization over Exposed Porous Polyethylene Orbital Implant (Medpor^®) in the Rabbit Model

REFERENCES

• Chalasani R, Poole-Warren L, Conway RM, et al. Porous orbital implants in enucleation: a systematic review. Surv Ophthalmol 2007;52:145–55.
   PubMed Web of Science ®Google Scholar
• Karesh JW, Dresner SC. High-density porous polyethylene (Medpor) as a successful anophthalmic socket implant. Ophthalmology 1994;101:1688–95.
   PubMed Web of Science ®Google Scholar
• Remulla HD, Rubin PA, Shore JW, et al. Complication of porous spherical orbital implant. Ophthalmology 1995;102:586–93.
   PubMed Web of Science ®Google Scholar
• Custer PL, Trinkaus KM. Porous implant exposure: Incidence, management, and morbidity. Ophthal Plast Reconstr Surg 2007;23:1–7.
   PubMed Web of Science ®Google Scholar
• Karcioglu ZA, Al-Mesfer SA, Mullaney PB. Porous polyethylene orbital implant in patients with retinoblastoma. Ophthalmology 1998;105:1311–6.
   PubMed Web of Science ®Google Scholar
• Lee V, Subak-Sharpe I, Hungerford JL, et al. Exposure of primary orbital implants in postenucleation retinoblastoma patients. Ophthalmology 2000;107:940–5.
   PubMed Web of Science ®Google Scholar
• Li T, Shen J, Duffy MT. Exposure rates of wrapped and unwrapped orbital implants following enucleation. Ophthal Plast Reconstr Surg 2001;17:431–5.
   PubMed Web of Science ®Google Scholar
• Sagoo MS, Olver JM. Autogenous temporalis fascia patch graft for porous polyethylene (Medpor) sphere orbital implant exposure. Br J Ophthalmol 2004;88:942–6.
   PubMed Web of Science ®Google Scholar
• Tawfik HA., Budin H, Dutton JJ. Repair of exposed porous polyethylene implants utilizing flaps from the implant capsule. Ophthalmology 2004;112:516–23.
   Web of Science ®Google Scholar
• Inkster CF, Ng SGJ, Leatherbarrow B. Primary banked scleral patch graft in the prevention of exposure of hydroxyapatite orbital implants. Ophthalmology 2002; 109:389–92.
   PubMed Web of Science ®Google Scholar
• Liao SL, Kao SC, Tseng JH, Lin LK. Surgical coverage of exposed hydroxyapatite implant with retroauricular myoperiosteal graft. Br J Ophthalmol 2005;89:92–5.
   PubMed Web of Science ®Google Scholar
• Geerling G, Maclennan S, Hartwig D. Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol 2004;88:1467–74.
   PubMed Web of Science ®Google Scholar
• Matsuo H, Tomidokoro A, Tomita G, Araie M. Topical application of autologous serum for the treatment of late-onset aqueous oozing or point-leak through filtering bleb. Eye 2005;19:23–8.
   PubMed Web of Science ®Google Scholar
• Rubin LR. Polyethylene as a bone and cartilage substitute: a 32-year retrospective. In: Rubin LR, ed. Biomaterials in Reconstructive Surgery. St Louis, MO: CV Mosby;1983;474–93.
   Google Scholar
• Bilyk JR, Rubin PAD, Shore JW. Correction of enophthalmos with porous polyethylene implants. Int Ophthalmol Clin 1992;32:151–2.
   PubMedGoogle Scholar
• Buettner H, Bartley GB. Tissue breakdown and exposure associated with orbital hydroxyapatite implants. Am J Ophthalmol 1992;113:669–73.
   PubMed Web of Science ®Google Scholar
• Gayre GS, Lipham W, Dutton JJ. A comparison of rates of fibrovascular ingrowth in wrapped versus unwrapped hydroxyapatite spheres in a rabbit model. Ophthal Plast Reconstr Surg 2002;18:275–80.
   PubMed Web of Science ®Google Scholar
• Blaydon AM, Shepler TR, Neuhaus RW, et al. The porous polyethylene (Medpor) spherical orbital implant. Ophthal Plast Reconstr Surg 2003;19:366–71.
   Web of Science ®Google Scholar
• Alwitry A, West S, Foss AJ, et al. Long-term follow-up of porous polyethylene spherical implants after enucleation and evisceration. Ophthal Plast Reconstr Surg 2007;23:11–5.
   PubMed Web of Science ®Google Scholar
• Goldberg RA, Holds JB, Ebrahimpour J. Exposed hydroxyapatite orbital implants: Reports of six cases. Ophthalmology 1992;99:831–6.
   PubMed Web of Science ®Google Scholar
• Kostick DA, Linberg JV. Evisceration with hydroxyapatite implant: Surgical technique and review of 31 case reports. Ophthalmology 1995;102:1542–9.
   PubMed Web of Science ®Google Scholar
• Yang JG, Khwarg SI, Wee WR, et al. Hydroxyapatite implantation with scleral quadrisection after evisceration. Ophthalmic Surg Lasers 1997;28:915–9.
   PubMedGoogle Scholar
• Pelletier CR, Jordan DR, Gilberg SM. Use of temporalis fascia for exposed hydroxyapatite orbital implants. Ophthal Plast Reconstr Surg 1998;14:198–203.
   PubMed Web of Science ®Google Scholar
• Helveston EM. Human bank scleral patch for repair of exposed or extruded orbital implants. Arch Ophthalmol 1969; 82:83–6.
   PubMedGoogle Scholar
• Fountain JA, Helveston EM. A long-term follow-up study of scleral grafting for exposed or extruded orbital implants. Am J Ophthalmol 1982;93:52–6.
   PubMed Web of Science ®Google Scholar
• Ang LP, Tan DT, Phan TT, et al. The in vitro and in vivo proliferative capacity of serum-free cultivated human conjunctival epithelial cells. Curr Eye Res. 2004;28:307–17.
   PubMed Web of Science ®Google Scholar
• Tsubota K, Goto E, Fujita H, et al. Treatment of dry eye by autologous serum application in Sjogren`s syndrome. Br J Ophthalmol 1999;83:390–5.
   PubMed Web of Science ®Google Scholar
• Cui H, Li H. Effect of basic fibroblast growth factor (bFGF) on the treatment of exposure of the orbital implants. J Zhejiang Univ Sci B 2007;8:620–6.
   PubMedGoogle Scholar
• Tsubota K, Goto E, Shimmura S, Shimazaki J. Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology 1999; 106:1984–9.
   PubMed Web of Science ®Google Scholar
• Poon AC, Geerling G, Dart JK, et al. Autologous serum eye drops for dry eyes and epithelial defects: Clinical and in vitro toxicity studies. Br J Ophthalmol 2001; 85:1188–97.
   PubMed Web of Science ®Google Scholar
• Herminghaus P, Hartwig D, Wedel T, et al. Epitheliotrophic capacity of serum and plasma eye drops. Influence of centrifugation. Ophthalmologe 2004; 101:998–1005.
   PubMed Web of Science ®Google Scholar